The Onderstepoort Biological Products (OBP) is a state-owned company that operates in terms of the Onderstepoort Biological Products Incorporation Act, 1999 (No. 19 of 1999). The mandate of the OBP is the manufacturing of veterinary medication for the prevention and control of animal diseases that impact on food security, human health and livelihoods. The OBP is operating without a Board, but the OBP management took a decision that all business will operate as usual until a Board is appointed. The Board ceased to exist in October 2010. The organisation had been reluctant to present the Strategic Plan that was not approved by the Board to the Committee. It has been difficult to operate without an oversight body.